Serotonin-dopamine interactions in social anxiety disorder

ppsala university0 个研究点目标入组 52 人开始时间: 2019年2月8日最近更新: 2023年5月15日

适应症

试验速览

暂无简介。

•1. Social anxiety disorder according to DSM-5, must be the main diagnosis as assessed with the structured clinical interview for DSM disorders (SCID) and the MINI interview
•2. Otherwise somatically healthy
•3. Age 18-64
•4. Willingness to participate in a brain imaging trial (giving informed consent)

•1. Treatment of social anxiety within the three months preceding the study
•2. Current serious or dominant psychiatric disorder other than social anxiety disorder (e.g. psychosis, major depressoin, bipolar disorder)
•3. Suicidal ideation
•4. Chronic use of other prescribed medication that could influence the results (e.g. antidepressants, anxiolytics, certain sleeping pills and herbal drugs like St John's Wort)
•5. Abuse of alcohol or narcotics
•6. Pregnancy of planned pregnancy during the study period
•7. Menopause
•8. Previous PET examination
•9. Contraindications for MRI investigation (e.g implants or other metal objects in the body, brain and heart operations)
•10. Heart insufficiency or previous heart surgery
•11. Contraindications for treatment with escitalopram

发起方

ppsala university